FEops Heartguide Platform Receives CE Mark Approval for Planning Structural Heart Interventions


April 1, 2019—FEops announced CE Mark approval for the Heartguide procedural planning environment for structural heart interventions. The technology provides physicians with insights to evaluate device sizing and positioning preoperatively using novel computational modeling and simulation technology. The current release includes workflows for transcatheter aortic valve replacement (TAVR) and left atrial appendage occlusion (LAAO) procedures.

According to the company, the Heartguide helps to assess the risk of potential complications by preoperatively simulating multiple treatment scenarios in terms of device sizing and positioning, both for TAVR and LAAO. Within the TAVR workflow, it is also possible to plan TAVR procedures for patients with bicuspid aortic valve stenosis, which is increasing in incidence with a shift toward treating low-risk patients.

FEops, which is based in Gent, Belgium, stated that the Heartguide cloud-based procedural planning environment uses advanced personalized computational modeling and simulation to preoperatively provide clinicians and medical device manufacturers with insights into the interaction between transcatheter structural heart devices and specific patient anatomy.

In the company's announcement, Cameron Dowling, MD, of St George’s Hospital in London, United Kingdom, commented, “FEops Heartguide gives our team increased confidence to perform TAVR in the most challenging of aortic valve anatomies.”

Ole De Backer, MD, of Rigshospitalet in Copenhagen, Denmark, added, “I have the strong hope, and believe that preprocedural planning with FEops Heartguide will transform percutaneous LAA closure into an even more safe and more efficient procedure for patients with nonvalvular atrial fibrillation and contraindications for oral anticoagulant therapy.”


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.